Results 101 to 110 of about 166,060,163 (163)

Time, History, and Providence in the Philosophy of Nicholas of Cusa

, 2021
Embora Nicholas de Cusa ocasionalmente tenha discutido que o Universo deva ser entendido como o desdobramento do absolutamente infinito de tempo, ele deixou perguntas abertas sobre a distinção entre tempo natural e tempo histórico, como qualquer noção de
Aleksander, Jason
core  

Possest : indications for thinking relationality principle in Nicholas of Cusa [PDF]

, 2014
We hope to achieve with the term possest one name, like other divine names, leading to the understanding of the principle. In this case, more specifically, we believe that possest indicates as enigma, the trinity of principle and further speculates ...
Teixeira Neto, José
core  

Pituitary society expert Delphi consensus: operative workflow in endoscopic transsphenoidal pituitary adenoma resection. [PDF]

Pituitary, 2021
Marcus HJ, Khan DZ, Borg A, Buchfelder M, Cetas JS, Collins JW, Dorward NL, Fleseriu M, Gurnell M, Javadpour M, Jones PS, Koh CH, Layard Horsfall H, Mamelak AN, Mortini P, Muirhead W, Oyesiku NM, Schwartz TH, Sinha S, Stoyanov D, Syro LV, Tsermoulas G, Williams A, Winder MJ, Zada G, Laws ER.   +25 more
europepmc   +1 more source

La concepción intelectual de lo divino como coincidentia oppositorum a la luz de lo maximum et minimum absolutum en el pensamiento de Nicolás de Cusa

Princípios, 2012
On February 12, 1440 Nicholas of Cusa (1401-1464) concludes in his birthplace of Kues drafting the first major systematic formulation of his thinking: De docta ignorantia. The main category of his metaphysics in this context, i.e.
José González Rios
doaj  

Gerhard Giebisch and the Gift of Mentorship. [PDF]

Kidney360, 2020
Aronson PS.
europepmc   +1 more source

A non-religious spirituality from a Christian tradition

Horizonte, 2014
Rapid changes in the ways of survival in human societies, passing quickly from pre-industrial to industrial societies or industrial societies to knowledge societies, characterized by innovation and constant change, require a kind of a non religious ...
Marià Corbí
doaj  

Characteristics associated with poor COVID-19 outcomes in people with psoriasis, psoriatic arthritis and axial spondyloarthritis: data from the COVID-19 PsoProtect and Global Rheumatology Alliance physician-reported registries. [PDF]

Ann Rheum Dis, 2023
Machado PM, Schäfer M, Mahil SK, Liew J, Gossec L, Dand N, Pfeil A, Strangfeld A, Regierer AC, Fautrel B, Alonso CG, Saad CGS, Griffiths CEM, Lomater C, Miceli-Richard C, Wendling D, Alpizar Rodriguez D, Wiek D, Mateus EF, Sirotich E, Soriano ER, Ribeiro FM, Omura F, Rajão Martins F, Santos H, Dau J, Barker JN, Hausmann J, Hyrich KL, Gensler L, Silva L, Jacobsohn L, Carmona L, Pinheiro MM, Zelaya MD, Severina MLÁ, Yates M, Dubreuil M, Gore-Massy M, Romeo N, Haroon N, Sufka P, Grainger R, Hasseli R, Lawson-Tovey S, Bhana S, Pham T, Olofsson T, Bautista-Molano W, Wallace ZS, Yiu ZZN, Yazdany J, Robinson PC, Smith CH.   +53 more
europepmc   +1 more source

Association Between Tumor Necrosis Factor Inhibitors and the Risk of Hospitalization or Death Among Patients With Immune-Mediated Inflammatory Disease and COVID-19.

JAMA Netw Open, 2021
Izadi Z, Brenner EJ, Mahil SK, Dand N, Yiu ZZN, Yates M, Ungaro RC, Zhang X, Agrawal M, Colombel JF, Gianfrancesco MA, Hyrich KL, Strangfeld A, Carmona L, Mateus EF, Lawson-Tovey S, Klingberg E, Cuomo G, Caprioli M, Cruz-Machado AR, Mazeda Pereira AC, Hasseli R, Pfeil A, Lorenz HM, Hoyer BF, Trupin L, Rush S, Katz P, Schmajuk G, Jacobsohn L, Seet AM, Al Emadi S, Wise L, Gilbert EL, Duarte-García A, Valenzuela-Almada MO, Isnardi CA, Quintana R, Soriano ER, Hsu TY, D'Silva KM, Sparks JA, Patel NJ, Xavier RM, Marques CDL, Kakehasi AM, Flipo RM, Claudepierre P, Cantagrel A, Goupille P, Wallace ZS, Bhana S, Costello W, Grainger R, Hausmann JS, Liew JW, Sirotich E, Sufka P, Robinson PC, Machado PM, Griffiths CEM, Barker JN, Smith CH, Yazdany J, Kappelman MD, Psoriasis Patient Registry for Outcomes, Therapy and Epidemiology of COVID-19 Infection (PsoProtect); the Secure Epidemiology of Coronavirus Under Research Exclusion for Inflammatory Bowel Disease (SECURE-IBD); and the COVID-19 Global Rheumatology Allianc, Psoriasis Patient Registry for Outcomes, Therapy and Epidemiology of COVID-19 Infection (PsoProtect); the Secure Epidemiology of Coronavirus Under Research Exclusion for Inflammatory Bowel Disease (SECURE-IBD); and the COVID-19 Global Rheumatology Alliance (GRA).   +68 more
europepmc   +1 more source

Nicholas of Cusa: The Catholic Concordance

, 1991
null Nicholas of Cusa
core   +1 more source